Literature DB >> 11043760

High-performance liquid chromatography method for the determination and quantitation of arabinosylguanine triphosphate and fludarabine triphosphate in human cells.

C O Rodriguez1, W Plunkett, M T Paff, M Du, B Nowak, P Ramakrishna, M J Keating, V Gandhi.   

Abstract

A gradient anion-exchange high-performance liquid chromatographic assay was developed for the simultaneous determination and quantitation of the cytotoxic triphosphates of arabinosylguanine (ara-GTP) and fludarabine (F-ara-ATP). The method was validated with respect to selectivity, recovery, linearity, precision, and accuracy using authentic standards. To test this assay in a more complex biological matrix, perchloric acid extracts of circulating human leukemia cells spiked with known concentrations of ara-GTP and F-ara-ATP were examined. Finally, to assess the clinical utility of our method, perchloric acid extracts of circulating human leukemia cells isolated from patients treated with fludarabine and nelarabine were analyzed. The range of quantitation was 0.0125-10 nmol for the ara- and native NTPs in cellular extracts. This assay should be helpful in establishing the mechanistic rationales for drug scheduling and combinations of nelarabine and fludarabine, and for correlating the therapeutic efficacy and levels of the cytotoxic triphosphates in target cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11043760     DOI: 10.1016/s0378-4347(00)00303-0

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  8 in total

1.  Cell death of bioenergetically compromised and transcriptionally challenged CLL lymphocytes by chlorinated ATP.

Authors:  Kumudha Balakrishnan; Christine M Stellrecht; Davide Genini; Mary Ayres; William G Wierda; Michael J Keating; Lorenzo M Leoni; Varsha Gandhi
Journal:  Blood       Date:  2005-02-17       Impact factor: 22.113

2.  Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

Authors:  Rathi N Pillai; Lisa S Chen; Mary L Ayres; Billie J Nowak; Michael W Thomas; Elizabeth J Shpall; Michael J Keating; Varsha Gandhi
Journal:  Leuk Lymphoma       Date:  2012-04-23

3.  A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia.

Authors:  Isam Abdel-Karim; William K Plunkett; Susan O'Brien; Francis Giles; Deborah Thomas; Stefan Faderl; Farhad Ravandi; Mary Beth Rios; Min Du; Karen B Schneck; Victor J Chen; Boris K Lin; Steven J Nicol; Hagop M Kantarjian
Journal:  Invest New Drugs       Date:  2010-01-21       Impact factor: 3.850

4.  Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines.

Authors:  Taichun Qin; Jaroslav Jelinek; Jiali Si; Jingmin Shu; Jean-Pierre J Issa
Journal:  Blood       Date:  2008-10-17       Impact factor: 22.113

5.  Inhibition of ATP synthase by chlorinated adenosine analogue.

Authors:  Lisa S Chen; Billie J Nowak; Mary L Ayres; Nancy L Krett; Steven T Rosen; Shuxing Zhang; Varsha Gandhi
Journal:  Biochem Pharmacol       Date:  2009-05-27       Impact factor: 5.858

6.  Intracellular succinylation of 8-chloroadenosine and its effect on fumarate levels.

Authors:  Jennifer B Dennison; Mary L Ayres; Kumar Kaluarachchi; William Plunkett; Varsha Gandhi
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

7.  Expression of ABCC-type nucleotide exporters in blasts of adult acute myeloid leukemia: relation to long-term survival.

Authors:  Yanping Guo; Kathleen Köck; Christoph A Ritter; Zhe-Sheng Chen; Markus Grube; Gabriele Jedlitschky; Thomas Illmer; Mary Ayres; James F Beck; Werner Siegmund; Gerhard Ehninger; Varsha Gandhi; Heyo K Kroemer; Gary D Kruh; Markus Schaich
Journal:  Clin Cancer Res       Date:  2009-02-24       Impact factor: 12.531

8.  Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19.

Authors:  James F Demarest; Maryline Kienle; RuthMabel Boytz; Mary Ayres; Eun Jung Kim; J J Patten; Donghoon Chung; Varsha Gandhi; Robert A Davey; David B Sykes; Nadim Shohdy; John C Pottage; Vikram S Kumar
Journal:  Antiviral Res       Date:  2022-08-28       Impact factor: 10.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.